DTU Logo
Overview | 4-T | ACE | ADOPT | AFORRD | DREAM | EDIT | EXSCEL | FHS | GLINT | ISAT | LDS | NAVIGATOR | TECOS | UKPDS

Acarbose Cardiovascular Evaluation



Trial Management

Steering Committee (SC)

Rury Holman UK Endocrinologist (Chair)
Hu Dayi China Cardiologist (Co-Chair)
Pan Changyu China Endocrinologist (Co-Chair)
       
Chen Jialun China Endocrinologist (Honoured adviser)
       
Juliana Chan Hong Kong Endocrinologist  
Jean-Louis Chiasson Canada Endocrinologist  
Ge Junbo China Cardiologist  
Yong Huo China Cardiologist  
Hertzel Gerstein Canada Endocrinologist  
John McMurray UK Cardiologist  
Lars Rydén Sweden Cardiologist  
Michal Tendera Poland Cardiologist  
Jaakko Tuomilehto Finland Epidemiologist  
Yang Wenying China Endocrinologist  
Stefan Schröder Germany Bayer  
Zig Lang China Bayer  

Data Safety Monitoring Board (DSMB)

Jean Rouleau Canada Cardiologist (Chair)
Jane Collier UK Hepatologist  
Stuart Pocock UK Statistician  
Eberhard Standl Germany Endocrinologist  
Karl Swedberg Sweden Cardiologist  
Weng Jianping China Endocrinologist  
Dong Zhao China Cardiologist  

Endpoint Adjudication Commitees

An independent Chinese Cardiovascular Event Adjudication Committee (CCVEAC) will review all cardiovascular endpoints.

Any occurrences of new-onset diabetes not diagnosed per protocol will be reviewed by the Diabetes Event Adjudication Committee (DEAC).